CNBC Investing Club

We're selling some shares of this outperforming drugmaker to pocket gains

In this May 2020 photo provided by Eli Lilly, researchers prepare mammalian cells to produce possible COVID-19 antibodies for testing in a laboratory in Indianapolis.
David Morrison | Eli Lilly via AP

More In CNBC Investing Club Newsletter

CNBC Investing ClubNew analyst reports support our view of Constellation as a great defensive play
CNBC Investing ClubWall Street notes on Apple, Qualcomm highlight the long-term opportunities in those stocks
CNBC Investing ClubTuesday's market bounce allows us to raise some cash to buy in the next downturn